Emergent BioSolutions Inc

2026. szept. 3. 20:03 UTC

Emergent BioSolutions faces investigation amid $191.3 million impairment charge and $180.2 million net loss, contributing to shares trading lower today.

2026. szept. 2. 19:53 UTC

Emergent BioSolutions Inc. is under investigation related to recent financial disclosures, following a significant net loss and reduced revenue guidance. Shares are higher today.

2026. szept. 1. 20:09 UTC

Emergent BioSolutions secures a $24 million contract modification from BARDA for its anthrax vaccine, CYFENDUS®, as shares rise in Tuesday trading.

2026. aug. 31. 20:02 UTC

Emergent BioSolutions secures a Canadian government contract for NARCAN® Nasal Spray, boosting shares during Monday's session. The agreement runs from October 2026 to September 2029.

2026. aug. 28. 20:07 UTC

Emergent BioSolutions shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, following a $191.3 million impairment charge and reduced revenue guidance.

2026. aug. 27. 20:07 UTC

Emergent BioSolutions Inc. is under investigation, following a $180.2 million net loss and reduced revenue guidance, contributing to a decline in shares today.

2026. aug. 26. 20:08 UTC

Emergent BioSolutions Inc shares are higher, reflecting strong upward momentum since Tuesday. The stock remains well above its 20-day moving average.

2026. aug. 25. 20:07 UTC

Emergent BioSolutions Inc shares are higher during Tuesday's session, continuing a strong advance since Monday's close amid easing Treasury yields and lower oil prices.

2026. aug. 24. 19:51 UTC

Emergent BioSolutions Inc shares are higher today, continuing a cumulative increase since Friday. The stock remains below its 20-day moving average.

2026. aug. 21. 19:51 UTC

Emergent BioSolutions Inc shares are higher today, continuing a steady upward trend since Thursday's close. No specific news was identified to explain the movement.

2026. aug. 20. 19:02 UTC

Emergent BioSolutions Inc faces scrutiny after a $191.3 million impairment charge and a reduced revenue outlook, contributing to a decline in shares.

2026. aug. 19. 19:52 UTC

Emergent BioSolutions Inc is trading higher during Wednesday's session, recovering from earlier lows and reflecting strength since Tuesday's close. No specific news was identified.

2026. aug. 18. 20:06 UTC

Emergent BioSolutions Inc shares are higher today, reflecting a broader market recovery. The stock remains below its 20-day moving average and prior month levels.

2026. aug. 17. 19:56 UTC

Emergent BioSolutions faces investigations over financial disclosures, including a $191.3 million impairment charge, contributing to lower shares amid declining investor confidence.

2026. aug. 13. 19:51 UTC

Emergent BioSolutions Inc shares are roughly flat as jobless claims rise to 209,000, exceeding expectations. The stock remains below its 20-day moving average.

2026. aug. 12. 19:26 UTC

Emergent BioSolutions Inc gains amid broader market optimism following inflation data. The stock reached a session high before slightly pulling back.

2026. aug. 11. 22:56 UTC

Emergent BioSolutions Inc shares are trading lower in after-market hours. No specific news was identified to explain the movement.

2026. aug. 10. 19:51 UTC

Emergent BioSolutions shares are trading lower as H.C. Wainwright reduced its price target to $10.00, citing concerns over performance and outlook amid competitive pressures.

2026. aug. 7. 23:26 UTC

Emergent BioSolutions Inc shares rose in after-market trading, amid positive market sentiment and notable gains in major tech stocks. No specific news was identified.

2026. aug. 6. 23:41 UTC

Emergent BioSolutions traded roughly flat after market hours, with no specific news identified. The stock has declined significantly over the past month.

2026. aug. 5. 22:51 UTC

Emergent BioSolutions shares are lower in after-market hours following a Q2 net loss of $180.2 million and reduced full-year sales guidance.

2026. júl. 29. 19:56 UTC

Emergent BioSolutions Inc shares are trading higher Wednesday, reflecting gains since Tuesday's close, despite earlier fluctuations and broader market pressures.

2026. júl. 27. 18:46 UTC

Emergent BioSolutions Inc shares are higher amid a broader market trend, despite pulling back from earlier session highs. Crude oil prices have significantly declined.

2026. júl. 23. 19:36 UTC

Emergent BioSolutions Inc shares are lower, reflecting broader market trends amid negative earnings from major technology companies like Tesla and Alphabet.